| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3331770 | Hematology/Oncology Clinics of North America | 2009 | 19 Pages |
Abstract
Plasma cell myeloma is a heterogenous disease with variable clinical presentation and outcome. The prognosis is largely determined by tumor biology. Newer therapeutic agents are rapidly changing the survival outlook of myeloma patients.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Pei Lin,